OBINUTUZUMAB
UNII O43472U9X8

Substance Identification & Data

This profile provides standardized clinical and technical data for Obinutuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O43472U9X8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 949142-50-1 and the RxNorm Concept ID (RxCUI) 974779. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O43472U9X8

CAS Registry Number

949142-50-1

RxNorm Concept ID

974779

Detailed Substance Profile

Preferred Name

OBINUTUZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

O43472U9X8

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C70741

National Cancer Institute reference terminology for clinical and research data.

INN ID

9043

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

UU-119

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Obinutuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OBINUTUZUMAB

Common Names & Synonyms

AFUTUZUMAB

HUMABCD20

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER

OBINUTUZUMAB [INN]

OBINUTUZUMAB [JAN]

OBINUTUZUMAB [MART.]

OBINUTUZUMAB [MI]

OBINUTUZUMAB [PURPLE BOOK CDER]

OBINUTUZUMAB [USAN]

OBINUTUZUMAB [VANDF]

OBINUTUZUMAB [WHO-DD]